Near-infrared imaging of injured tissue in living subjects using IR-820

Charles Keller, Suresh I. Prajapati, Carlo O. Martinez, Ali N. Bahadur, Isabel Q. Wu, Wei Zheng, James D. Lechleiter, Linda M. McManus, Gary B. Chisholm, Joel E. Michalek, Paula K. Shireman

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

The unprecedented increase in preclinical studies necessitates high-throughput, inexpensive, and straightforward methods for evaluating diseased tissues. Near-infrared imaging of live subjects is a versatile, cost-effective technology that can be effectively used in a variety of pathologic conditions. We have characterized an inexpensive optoelectronic chemical, IR-820, as an infrared blood pool contrast agent to detect and quantify diseased tissue in live animals. IR-820 has maximal excitation and emission wavelengths of 710 and 820 nm, respectively. IR-820 emission is significantly improved in vivo on serum binding to albumin, and elimination occurs predominantly via the gastrointestinal tract. We demonstrate the utility of this contrast agent for serially imaging of traumatized tissue (muscle), tissue following reperfusion (eg, stroke), and tumors. IR-820 can also be employed to map regional lymph nodes. This novel contrast agent is anticipated to be a useful and an inexpensive tool for screening a wide variety of preclinical models of human diseases.

Original languageEnglish (US)
Pages (from-to)45-54
Number of pages10
JournalMolecular Imaging
Volume8
Issue number1
DOIs
StatePublished - Jan 2009
Externally publishedYes

Fingerprint

Infrared imaging
Tissue
Contrast Media
lymphatic system
muscles
strokes
albumins
Optoelectronic devices
serums
Reperfusion
blood
Muscle
animals
Gastrointestinal Tract
Tumors
Albumins
elimination
Screening
Animals
Blood

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Biotechnology
  • Molecular Medicine
  • Biomedical Engineering
  • Condensed Matter Physics

Cite this

Keller, C., Prajapati, S. I., Martinez, C. O., Bahadur, A. N., Wu, I. Q., Zheng, W., ... Shireman, P. K. (2009). Near-infrared imaging of injured tissue in living subjects using IR-820. Molecular Imaging, 8(1), 45-54. https://doi.org/10.2310/7290.2009.00005

Near-infrared imaging of injured tissue in living subjects using IR-820. / Keller, Charles; Prajapati, Suresh I.; Martinez, Carlo O.; Bahadur, Ali N.; Wu, Isabel Q.; Zheng, Wei; Lechleiter, James D.; McManus, Linda M.; Chisholm, Gary B.; Michalek, Joel E.; Shireman, Paula K.

In: Molecular Imaging, Vol. 8, No. 1, 01.2009, p. 45-54.

Research output: Contribution to journalArticle

Keller, C, Prajapati, SI, Martinez, CO, Bahadur, AN, Wu, IQ, Zheng, W, Lechleiter, JD, McManus, LM, Chisholm, GB, Michalek, JE & Shireman, PK 2009, 'Near-infrared imaging of injured tissue in living subjects using IR-820', Molecular Imaging, vol. 8, no. 1, pp. 45-54. https://doi.org/10.2310/7290.2009.00005
Keller C, Prajapati SI, Martinez CO, Bahadur AN, Wu IQ, Zheng W et al. Near-infrared imaging of injured tissue in living subjects using IR-820. Molecular Imaging. 2009 Jan;8(1):45-54. https://doi.org/10.2310/7290.2009.00005
Keller, Charles ; Prajapati, Suresh I. ; Martinez, Carlo O. ; Bahadur, Ali N. ; Wu, Isabel Q. ; Zheng, Wei ; Lechleiter, James D. ; McManus, Linda M. ; Chisholm, Gary B. ; Michalek, Joel E. ; Shireman, Paula K. / Near-infrared imaging of injured tissue in living subjects using IR-820. In: Molecular Imaging. 2009 ; Vol. 8, No. 1. pp. 45-54.
@article{917589bdcb83406a917455b2f50a7755,
title = "Near-infrared imaging of injured tissue in living subjects using IR-820",
abstract = "The unprecedented increase in preclinical studies necessitates high-throughput, inexpensive, and straightforward methods for evaluating diseased tissues. Near-infrared imaging of live subjects is a versatile, cost-effective technology that can be effectively used in a variety of pathologic conditions. We have characterized an inexpensive optoelectronic chemical, IR-820, as an infrared blood pool contrast agent to detect and quantify diseased tissue in live animals. IR-820 has maximal excitation and emission wavelengths of 710 and 820 nm, respectively. IR-820 emission is significantly improved in vivo on serum binding to albumin, and elimination occurs predominantly via the gastrointestinal tract. We demonstrate the utility of this contrast agent for serially imaging of traumatized tissue (muscle), tissue following reperfusion (eg, stroke), and tumors. IR-820 can also be employed to map regional lymph nodes. This novel contrast agent is anticipated to be a useful and an inexpensive tool for screening a wide variety of preclinical models of human diseases.",
author = "Charles Keller and Prajapati, {Suresh I.} and Martinez, {Carlo O.} and Bahadur, {Ali N.} and Wu, {Isabel Q.} and Wei Zheng and Lechleiter, {James D.} and McManus, {Linda M.} and Chisholm, {Gary B.} and Michalek, {Joel E.} and Shireman, {Paula K.}",
year = "2009",
month = "1",
doi = "10.2310/7290.2009.00005",
language = "English (US)",
volume = "8",
pages = "45--54",
journal = "Molecular imaging : official journal of the Society for Molecular Imaging",
issn = "1535-3508",
publisher = "Decker Publishing",
number = "1",

}

TY - JOUR

T1 - Near-infrared imaging of injured tissue in living subjects using IR-820

AU - Keller, Charles

AU - Prajapati, Suresh I.

AU - Martinez, Carlo O.

AU - Bahadur, Ali N.

AU - Wu, Isabel Q.

AU - Zheng, Wei

AU - Lechleiter, James D.

AU - McManus, Linda M.

AU - Chisholm, Gary B.

AU - Michalek, Joel E.

AU - Shireman, Paula K.

PY - 2009/1

Y1 - 2009/1

N2 - The unprecedented increase in preclinical studies necessitates high-throughput, inexpensive, and straightforward methods for evaluating diseased tissues. Near-infrared imaging of live subjects is a versatile, cost-effective technology that can be effectively used in a variety of pathologic conditions. We have characterized an inexpensive optoelectronic chemical, IR-820, as an infrared blood pool contrast agent to detect and quantify diseased tissue in live animals. IR-820 has maximal excitation and emission wavelengths of 710 and 820 nm, respectively. IR-820 emission is significantly improved in vivo on serum binding to albumin, and elimination occurs predominantly via the gastrointestinal tract. We demonstrate the utility of this contrast agent for serially imaging of traumatized tissue (muscle), tissue following reperfusion (eg, stroke), and tumors. IR-820 can also be employed to map regional lymph nodes. This novel contrast agent is anticipated to be a useful and an inexpensive tool for screening a wide variety of preclinical models of human diseases.

AB - The unprecedented increase in preclinical studies necessitates high-throughput, inexpensive, and straightforward methods for evaluating diseased tissues. Near-infrared imaging of live subjects is a versatile, cost-effective technology that can be effectively used in a variety of pathologic conditions. We have characterized an inexpensive optoelectronic chemical, IR-820, as an infrared blood pool contrast agent to detect and quantify diseased tissue in live animals. IR-820 has maximal excitation and emission wavelengths of 710 and 820 nm, respectively. IR-820 emission is significantly improved in vivo on serum binding to albumin, and elimination occurs predominantly via the gastrointestinal tract. We demonstrate the utility of this contrast agent for serially imaging of traumatized tissue (muscle), tissue following reperfusion (eg, stroke), and tumors. IR-820 can also be employed to map regional lymph nodes. This novel contrast agent is anticipated to be a useful and an inexpensive tool for screening a wide variety of preclinical models of human diseases.

UR - http://www.scopus.com/inward/record.url?scp=67649344506&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649344506&partnerID=8YFLogxK

U2 - 10.2310/7290.2009.00005

DO - 10.2310/7290.2009.00005

M3 - Article

AN - SCOPUS:67649344506

VL - 8

SP - 45

EP - 54

JO - Molecular imaging : official journal of the Society for Molecular Imaging

JF - Molecular imaging : official journal of the Society for Molecular Imaging

SN - 1535-3508

IS - 1

ER -